• Most Popular
  • Most Shared

UPDATE 1-Bavarian to file new claim vs Oxford Biomedica

Mon Jan 12, 2009 9:29am EST

Stocks

   

COPENHAGEN, Jan 12 (Reuters) - Denmark's Bavarian Nordic (BAVA.CO) said on Monday it would file a new patent infringement complaint in its suit against Britain's Oxford BioMedica (OXB.L) after a United States judge dismissed the first allegation.

Bavarian said in a statement it would file a new complaint within 14 days and the case was thus still pending.

Oxford BioMedica earlier on Monday said the U.S. District Court for the Southern District of California had dismissed the claim because it did not state a legal claim for patent infringement.

Bavarian claims that Oxford BioMedica has infringed its patents by commercializing patented technology in ways that have yielded large development payments for TroVax, a therapeutic cancer vaccine.

Oxford BioMedica argues that patent infringement actions could not yet be filed because TroVax is still being evaluated in clinical trials. (Reporting by Kim McLaughlin; Editing by Jon Loades-Carter)



More from Reuters

Federal Reserve Chairman Ben Bernanke is pictured at his Senate Banking, Housing and Urban Affairs Committee hearing on his nomination to continue as Chairman of the Board of Governors, on Capitol Hill in Washington, December 3, 2009. REUTERS/Jason Reed

No great expectations

Investors are getting antsy about when the Fed will tighten its purse strings, now that the economy appears to be coming back to life.   Full Article 

A long-range, improved Sejil 2 missile is test-fired in the desert at an unknown location in Iran in this Iranian military handout distributed by Fars news agency on December 16, 2009.

Iran tests upgraded missile

Hardline rulers send uncompromising signals to foes at home and abroad, testing a missile that could reach Israel and warning of legal action against opposition leaders.  Full Article | Video